When you evaluate an engineering partner, ask three things. Do they work inside your backlog and sprint cadence, or run a parallel one? Do their engineers join your standups and talk directly to your clinicians and lab staff? How soon are they shipping against your codebase rather than writing specs about it?

The embedded model trades handoff latency for domain context. It is the reason we place forward-deployed engineers inside client teams from our Delaware base: they pick up the domain quickly and ship inside the client's own sprint cycle instead of a separate one. https://nonstopio.com/forward-deployed-engineers/

Teams often treat HIPAA as something to verify just before release. In practice the expensive decisions are made at scoping: where PHI is stored and who can touch it, encryption in transit and at rest, audit logging, role-based access with minimum-necessary rules, and a BAA with every vendor in the chain.

Retrofitting these after an MVP usually means reworking the data model, not flipping a setting. For teams without the in-house bandwidth to run the whole cycle, here is how we structure it from early product scoping to a production-ready release: NonStopio's digital product development process.https://nonstopio.com/digital-product-development/

1) Where does PHI actually flow? Draw the data-flow map, including every third-party service and which of them needs a BAA. 2) Does the EHR or lab system you depend on expose the write access you need, and under what licensing? 3) Which compliance obligations change the architecture rather than just the paperwork? 4) What is the smallest slice that proves the integration works?
These answers are cheap to get at the architecture stage and expensive once code exists. Our Delaware-based team runs this as architecture review and technical due diligence for healthcare and genomics organizations, covering compliance readiness and integration feasibility before development starts.https://nonstopio.com/tech-consultation/

A portal that reads from the EHR on a nightly sync will always show patients stale data, and a provider dashboard fed by a different pipeline will disagree with it. Two decisions fix most of this early: which system is the source of truth for each data element (demographics, appointments, results, messages), and how changes propagate between systems (FHIR APIs or HL7 interfaces, event-driven or polled).
Then keep the first release to two or three flows, such as scheduling, results and secure messaging, so the integration is proven before the surface area grows. This connective layer between portals, dashboards and EHRs is the gap NonStopio's health-tech team focuses on for US healthcare organizations.https://nonstopio.com/health-tech/

If you are building software around genomic testing, the first trap is treating a sequencing order like any other lab order. A requisition-to-report workflow has distinct handoffs (accessioning, library prep, sequencing, secondary analysis, variant interpretation, clinician sign-off) and each one needs its own audit trail. Generic EHR lab modules usually model only the first and last step, so the middle ends up in spreadsheets and email. https://nonstopio.com/genomics/

The second gap is cascade screening. Once a pathogenic variant is confirmed, the system has to track which relatives should be offered testing and what consent exists. That is pedigree logic, not order logic. We documented how we handle LIMS integration, variant interpretation and cascade screening in NonStopio's genomics team, which is a useful reference if you are scoping something similar.